
HeartLogic Clinical Data
The evidence is resounding. HeartLogic is validated to have high sensitivity, the ability to provide weeks of advanced notice and low alert burden for detecting signs and symptoms of worsening heart failure.1 Explore the data and get the extraordinary technology that allows you to do things you couldn’t do before.
About MultiSENSE
MultiSENSE was an international, multicenter, non-randomized feasibility study designed to determine how ambulatory sensor measurements change with worsening heart failure. The goal of the study was to develop and validate a multi-sensor algorithm for the early detection of worsening heart failure. The study concluded that the HeartLogic multi-sensor index and alert algorithm provide a sensitive and timely predictor of impending heart failure decompensation.1

HFSA 2019 - HeartLogic Heart Failure Diagnostic - Validated Evidence, Clinical Implementation and Utility

Watch selected excerpts from Boston Scientific’s Contemporary Forum at HFSA 2019.
Featured Clinical Data

Results From the MultiSENSE Study:
HeartLogic Multisensor Algorithm Identifies Patients During Periods of Increased Risk of Heart Failure Events
Results From the MultiSENSE Study:
HeartLogic Multisensor Algorithm Identifies Patients During Periods of Increased Risk of Heart Failure Events
Abstracts

Share Your HeartLogic Insights
We’d love to hear your insights on HeartLogic, including best practices, workflow tips, heart failure case studies and testimonials.

Products
Your extraordinary talent. Our extraordinary technology. Explore the Boston Scientific CRT-Ds and ICDs that feature HeartLogic.
LATITUDE NXT™ Remote Patient Management System: Indications, Safety and Warnings
Resonate™ ICD: Indications, Safety and Warnings
Resonate™ CRT-D: Indications, Safety and Warnings
References
1. Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216-25.
* The HeartLogic Index and Alert were validated using data from the MultiSENSE study; however, HeartLogic’s impact on clinical outcome has not been established. Establishment of the impact will require a post market trial designed specifically to study clinical outcomes directly related to the use of this feature.